Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Apricus Biosciences Inc (NASDAQ:APRI)

1.74
Delayed Data
As of Dec 15
 0.00 / 0.00%
Today’s Change
0.86
Today|||52-Week Range
4.07
+33.85%
Year-to-Date
No recent news for Apricus Biosciences Inc.

Today’s Trading

Previous close1.74
Today’s open1.71
Day’s range1.68 - 1.75
Volume194,178
Average volume (3 months)253,436
Market cap$26.5M
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+70.20%
Earnings growth (this year)+105.13%
Earnings growth (next 5 years)--
Revenue growth (last year)+19.09%
P/E ratioNM
Price/Sales1.47
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CYCCCyclacel Pharmaceuti...0.000.00%
ACSTAcasti Pharma Inc0.000.00%
KTOVKitov Pharmaceutical...0.000.00%
HTBXHeat Biologics Inc0.000.00%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateMarch 13, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$5.8M
Annual profit (last year)-$7.4M
Net profit margin-128.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer, CAO, Secretary &
Director
Richard W. Pascoe
Chief Business Officer &
Senior Vice President
Neil C. Morton
Corporate headquarters
San Diego, California

Forecasts